PLTR vs PSTV · P/E 584, rev $3.57B vs P/E 0.2, rev $5.8M
Palantir Technologies Inc. Class A Common Stock (PLTR) versus Plus Therapeutics Inc (PSTV) — a side-by-side from cached financials, not a winner call.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
Latest reported PLTR revenue for 2026-06-30 was $3.57B. Net income was $1.93B. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
PLTR currently screens at market cap $317.08B and trailing P/E 584.2. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Not investment advice. Open the PLTR and PSTV stock pages for the full models.
Not investment advice.